Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature

Cefiderocol is a new siderophore cephalosporin with activity against carbapenem-resistant gram-negative bacteria. Data on its clinical efficacy are limited to complicated urinary tract infections. We present a series of 3 patients successfully treated with cefiderocol for complicated health care–ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Zingg, Sandra, Nicoletti, G Jacopo, Kuster, Sabine, Junker, Milena, Widmer, Andreas, Egli, Adrian, Hinic, Vladimira, Sendi, Parham, Battegay, Manuel, Bättig, Veronika, Khanna, Nina, Tschudin-Sutter, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284008/
https://www.ncbi.nlm.nih.gov/pubmed/32548207
http://dx.doi.org/10.1093/ofid/ofaa185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284008/
https://www.ncbi.nlm.nih.gov/pubmed/32548207
http://dx.doi.org/10.1093/ofid/ofaa185

Ejemplares similares